BIOMAT Database Logo BIOMAT Database Logo

Rheological studies of the contractile force within platelet-fibrin clots: effects of prostaglandin E1, dibutyryl-cAMP and dibutyryl-cGMP. 1978

M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson

UI MeSH Term Description Entries
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003994 Bucladesine A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) Dibutyryl Adenosine-3',5'-Monophosphate,Dibutyryl Cyclic AMP,(But)(2) cAMP,Bucladesine, Barium (1:1) Salt,Bucladesine, Disodium Salt,Bucladesine, Monosodium Salt,Bucladesine, Sodium Salt,DBcAMP,Dibutyryl Adenosine 3,5 Monophosphate,N',O'-Dibutyryl-cAMP,N(6),0(2')-Dibutyryl Cyclic AMP,AMP, Dibutyryl Cyclic,Adenosine-3',5'-Monophosphate, Dibutyryl,Cyclic AMP, Dibutyryl,Dibutyryl Adenosine 3',5' Monophosphate,Disodium Salt Bucladesine,Monosodium Salt Bucladesine,N',O' Dibutyryl cAMP,Sodium Salt Bucladesine
D003995 Dibutyryl Cyclic GMP N-(1-Oxobutyl)-cyclic 3',5'-(hydrogen phosphate)-2'-butanoate guanosine. A derivative of cyclic GMP. It has a higher resistance to extracellular and intracellular phosphodiesterase than cyclic GMP. Dibutyryl Guanosine-3',5'-Monophosphate,Dibutyryl Guanosine 3,5 Monophosphate,Cyclic GMP, Dibutyryl,Dibutyryl Guanosine 3',5' Monophosphate,GMP, Dibutyryl Cyclic,Guanosine-3',5'-Monophosphate, Dibutyryl
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012212 Rheology The study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY. Flowmetry,Velocimetry,Velocimetries
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Effects of dibutyryl cyclic adenosinemonophosphate and prostaglandin E1 on platelet aggregation and shape changes.
April 1977, American journal of clinical pathology,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Prostaglandin E1 and dibutyryl cyclic AMP enhance platelet resistance to deformation.
March 1992, Thrombosis research,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Further studies on the influence of dibutyryl cAMP, theophylline and prostaglandin E1 on composition and biosynthesis of phospholipids in Microsporum gypseum.
December 1989, Indian journal of biochemistry & biophysics,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Rheological studies of creep and creep recovery of unligated fibrin clots: comparison of clots prepared with thrombin and ancrod.
March 1985, Biopolymers,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Compartive behavioral effects of dibutyryl cyclic AMP and prostaglandin E1 in mice.
June 1975, Prostaglandins,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Platelet cAMP and cGMP Phosphodiesterases.
January 1995, Platelets,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Effects of dibutyryl cyclic AMP and prostaglandin E1 on cultured human glioma cells.
March 1974, Experimental cell research,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Effects of cyclic neucleotide monophosphates (cAMP, cGMP, cIMP, dibutyryl-cAMP) on transtubular net fluxes in rat kidneys.
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Metabolic requirements of contractile force generation in platelet rich plasma - a rheological study.
January 1980, Biorheology,
M S Kuntamukkula, and L V McIntire, and J L Moake, and D M Peterson, and W J Thompson
Prostaglandin E1 activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force.
March 1979, Molecular pharmacology,
Copied contents to your clipboard!